Ameritas Investment Company’s Gilead Sciences GILD Stock Holding History

Ameritas Investment Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$377K	Buy	5,398 +3,381	+168%	+$238K	0.02%	489
2021 Q2	$366K	Sell	2,017 -1,382	-41%	-$92.3K	0.02%	512
2021 Q1	$220K	Buy	+3,399	New	+$219K	0.02%	555
2020 Q2	–	Sell	-17,902	Closed	-$1.4M	–	819
2020 Q1	$1.4M	Buy	17,902 +17,002	+1,889%	+$1.17M	0.22%	74
2019 Q4	$58K	Sell	900 -3,609	-80%	-$235K	0.01%	555
2019 Q3	$290K	Buy	+4,509	New	+$295K	0.06%	267
2019 Q2	–	Sell	-4,704	Closed	-$306K	–	465
2019 Q1	$306K	Buy	+4,704	New	+$313K	0.06%	245

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameritas Investment Company's GILD Position: Q3 2021 in Review

Ameritas Investment Company increased its Gilead Sciences (GILD) stake by 168% in Q3 2021, buying an estimated $238K and bringing the position to 5,398 shares worth $377K. The position accounts for 0.02% of the portfolio, ranked #489.

Ameritas Investment Company first reported a position in GILD in Q1 2019 and has held it in 7 quarters since. The position peaked at $1.4M in Q1 2020. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

Ameritas Investment Company held 5,398 shares of Gilead Sciences worth $377K as of Q3 2021.
Ameritas Investment Company bought 3,381 Gilead Sciences shares in Q3 2021, an estimated $238K.
Gilead Sciences made up 0.02% of Ameritas Investment Company's portfolio in Q3 2021, its #489 holding.
Ameritas Investment Company first reported a position in Gilead Sciences in Q1 2019 and has held it in 7 quarters since.
Ameritas Investment Company's Gilead Sciences position peaked at $1.4M in Q1 2020.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.